Pfizer beat third-quarter expectations and raised its 2021 forecast again even as sales of its top product, the COVID-19 vaccine Comirnaty, slipped in the U.S. Soaring international sales of the preventive shots helped pushed total Comirnaty revenue close to $13 billion in the quarter, and the drugmaker said Tuesday that it now expects to book about $36 billion in sales from the vaccine this year
Related posts
-
‘We’re all in this together’: Hawthorn Woods looks for long-term water option
Hawthorn Woods working toward economically and logistically viable long-term water solutions -
Man faces sentencing for 2021 Round Lake bank robbery
The Lake County Attorney's Office said Francisco Martinez, 32, entered a First Midwest Bank branch in... -
Man charged with stealing from store, again, a few hours after release from jail
A man has been charged with stealing from the Oak Brook Macy’s store a few hours...